MedTrace Logo

Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test

NCT02734303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-03-04

No results posted yet for this study

Summary

Background:

The first nuclear bomb test took place in New Mexico in July 1945. This was called the Trinity test. Researchers want to learn how it affected the health of people who lived in New Mexico at the time of the test. To do this, they want to learn about the diet and daily life of those people at that time. They want to study Native Americans, Hispanic/Latinos, and non-Hispanic/Latino whites.

Objective:

To learn about the health risks for people who may have been exposed to radiation from the Trinity nuclear test.

Eligibility:

People who:

* Are Native American, Hispanic/Latino, or non-Hispanic white
* Are age 70 and older
* Lived near the fallout region of the Trinity test and know about lifestyle and dietary patterns in New Mexico in the 1940s and 1950s

Design:

Participants will be screened with a questionnaire.

Participants will answer questions in an interview or a focus group. This will be at a place like an office, tribal or community center, or library. It will take up to 2 hours. The interview or group session will include:

* Questions about their and their family members activities and eating habits in the 1940s and 1950s
* A card-sorting exercise: There will be cards with pictures and names of certain foods. They will sort the cards into 2 piles: those that were consumed and those that were not.
* Filling out a chart of their family members and the foods they ate

If participants give permission, their interview or group session will be recorded.

...

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Steven L Simon, Ph.D. · National Cancer Institute (NCI)

Eligibility

Min Age
70 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-17
Primary Completion
2017-09-12
Completion
2019-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734303 on ClinicalTrials.gov